An overview of [add local affiliate name]
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur. Excepteur sint occaecat cupidatat non proident, sunt in culpa qui officia.
Lorem ipsum dolor sit amet, consectetur adipiscing elit
Lorem ipsum dolor sit amet, consectetur adipiscing elit
Lorem ipsum dolor sit amet, consectetur adipiscing elit
Evolution: how to make treatments more accessible for more patients
Pharmaceutics is a dynamic science, constantly evolving to make every medicine, formula, and application more effective. Our commitment to accessibility drives us to provide significant benefits and enable more people to access targeted and effective treatments. In our four research hubs, we focus on identifying new dosing solutions for approved drugs, repurposing reformulations, and developing APIs to deliver high-quality generic medicines to the market, ensuring that healthcare is more inclusive.
News & Highlights
Lorem ipsum dolor sit amet, consectetur adipiscing elit
2024 - June 28
Combines AI to increase the potential of novel histone deacetylase (HDAC) inhibitors in the non-oncological field
2023 - September 7
7 September marks World Duchenne Awareness Day (WDAD), a disease in which we as a company are particularly involved.
2022 - September 7
September 7th is World Duchenne Muscular Dystrophy Awareness Day, a disease that sees us, as a company, at the forefront of the search for a drug that can slow down its progression.
2022 - July 26
Thanks to this operation, that is subject to the approval of the competition authorities, the Group will reach 1,300 employees in Spain and 3,500 globally, with a consolidated turnover of over 1 billion euros.